Local control in metastatic neuroblastoma in children over 1 year of age
Authors:
- Maria Antonietta De IorisMIMaria Antonietta De Ioris
- Alessandro CrocoliACAlessandro Crocoli
- Benedetta ContoliBCBenedetta Contoli
- Maria Carmen GarganeseMGMaria Carmen Garganese
- Gianluigi NataliGNGianluigi Natali
- Paolo TomàPTPaolo Tomà
- Alessandro JenknerAJAlessandro Jenkner
- Renata BoldriniRBRenata Boldrini
- Maria Debora De PasqualeMPMaria Debora De Pasquale
- Giuseppe Maria MilanoGMGiuseppe Maria Milano
- Silvia MadafferiSMSilvia Madafferi
- Aurora CastellanoACAurora Castellano
Open Access
- 21 February 2015
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-7
Abstract
Local control is always considered in metastatic neuroblastoma (NBL). The aim of this study is to evaluate the impact of radical surgery on survival in children over 1 year of age. Fifty-eight patients older than 1 year of age with metastatic NBL were treated with conventional plus high-dose chemotherapy with or without addition of local radiotherapy (RT, 21Gy). Surgery was classified as radical surgery (complete resection and gross total resection) or non-radical surgery. The Kaplan-Meier method and the Cox proportional hazard model were used to calculate the probability of progression free and overall survival (PFS and OS) and for multivariate analysis. The 5-year PFS and OS for patients with radical surgery were 26% (95% CI 14-40%) and 38% (95% CI 23-53%) respectively, while the PFS and OS for patients without radical surgery were 33% (95% CI 10-59%) and 31% (95% CI 10-55%) (respectively, P 0.85 and P 0.42). The 5-year PFS and OS for patients who received RT were 36% (95% CI 19-53%) and 46% (95% CI 26-64%) respectively, while the 5-year PFS and OS for patients who did not receive RT were 22% (95% CI 9-38%) and 27% (95% CI 13-42%) respectively (P 0.02 for PFS). Multivariate analysis confirmed the role of well-known prognostic factors, such as the presence of MYCN amplification, age and response before high-dose chemotherapy. Our data suggest that the degree of resection does not influence survival in metastatic NBL patients treated with high-dose chemotherapy; local RT contributes to local disease control.Keywords
This publication has 29 references indexed in Scilit:
- Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95 % tumour resection suffice?Pediatric Surgery International, 2012
- Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastomaEuropean Journal of Cancer, 2011
- Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experienceJournal of Pediatric Surgery, 2010
- Local control of the primary tumour in metastatic neuroblastomaEuropean Journal of Cancer, 2009
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group StudyJournal of Clinical Oncology, 2009
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialThe Lancet Oncology, 2008
- High dose melphalan in the treatment of advanced neuroblastoma: Results of a randomised trial (ENSG‐1) by the European Neuroblastoma Study GroupPediatric Blood & Cancer, 2004
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958